Concord Medical signed an agreement with the Beijing International Medical Center (BIMC) to establish the Beijing Concord Cancer Hospital (BCCH), a premium cancer specialized hospital. BIMC is a joint project initiated by the Beijing Municipal Government, the Ministry of Health and several other Chinese government agencies. Under the agreement, the BCCH will be wholly owned by Concord Medical and provide comprehensive cancer therapies, including surgery, chemotherapy, radiotherapy and gene therapy, to high-income patients. Concord Medical will provide management support, treatment, technology and research to the hospital, including protocols and clinical practice guidelines, by collaborating with top-notch cancer institutions around the world. CCM plans to begin designing of the hospital and other early-stage works in 2015.